Deborah A. Thomas

35.7k citations
451 papers · 23.2k · 6 hit papers · h-index 80

Impact in

  • Hematology top 0.01%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.01%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 136
    • Acute Myeloid Leukemia Research 126
    • Multiple Myeloma Research and Treatments 29
    • Chronic Lymphocytic Leukemia Research 191
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 47

Deborah A. Thomas

442 papers receiving 22.7k citations

Deborah A. Thomas's Hit Papers

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis 2010 · 847 citations
8470+8+17Years since publication250500750

Peers

Deborah A. Thomas
Comparison fields: 5 of 157
  • Hematology 12.3k
  • Genetics 10.2k
  • Pathology and Forensic Medicine 5.5k
  • Public Health, Environmental and Occupational Health 5.7k
  • Oncology 4.9k
Replace Stefan Faderl with:
Stefan Faderl United States
James W. Vardiman United States
Elias Jabbour United States
Zeev Estrov United States
Giuseppe Saglio Italy
Alessandra Ferrajoli United States
Farhad Ravandi United States
Michele Baccarani Italy
Charles A. Schiffer United States
Charles Koller United States
Deborah A. Thomas relative to Stefan Faderl United States Stefan Faderl's profile →
Citations per field
00.5×1.7×
Stefan Faderl · 1×
Citations per year

Countries citing papers authored by Deborah A. Thomas

Since Specialization
Citations

This map shows the geographic impact of Deborah A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Thomas more than expected).

Fields of papers citing papers by Deborah A. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Thomas. The network helps show where Deborah A. Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah A. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah A. Thomas Line = papers co-authored together Deborah A. Thomas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 451 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
Hit paper breakdown →
2006893
2
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Hit paper breakdown →
2010847
3
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
Hit paper breakdown →
2005704
4
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
Hit paper breakdown →
2003631
5
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Hit paper breakdown →
2000559
6
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Hit paper breakdown →
2008508
7 2001468
8 2004454
9 2003401
10 2005400
11 2003399
12 2006369
13 2012309
14 2007308
15 2010301
16 2003298
17 2010282
18 2007252
19 2006239
20 2013230

About Deborah A. Thomas

Deborah A. Thomas is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Molecular Biology, having authored 451 papers that have together received 23.2k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (198 papers), Chronic Lymphocytic Leukemia Research (191 papers), Chronic Myeloid Leukemia Treatments (136 papers), Acute Myeloid Leukemia Research (126 papers), Lymphoma Diagnosis and Treatment (93 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers), Multiple Myeloma Research and Treatments (29 papers) and Eosinophilic Disorders and Syndromes (28 papers). The work is most often cited by research in Hematology (12.3k citations), Genetics (10.2k citations), Pathology and Forensic Medicine (5.5k citations), Public Health, Environmental and Occupational Health (5.7k citations) and Oncology (4.9k citations). Deborah A. Thomas has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Hagop M. Kantarjian, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, Stefan Faderl, Guillermo Garcia‐Manero, Michael J. Keating, Srđan Verstovšek, Maher Albitar and Charles Koller. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact